Anti-Malarial Drug Resistance in Cameroon

NCT00146718 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

755

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Amodiaquine and Sulphadoxine/Pyrimethamine

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]